What is the recommended schedule for hepatitis B vaccine and hepatitis B immune globulin administration in a newborn, including timing and dosing based on the mother's hepatitis B surface antigen status?

Hepatitis B Immunoprophylaxis for Newborns

All newborns born to HBsAg-positive mothers must receive both hepatitis B vaccine and HBIG (0.5 mL) within 12 hours of birth, administered at separate anatomical sites, regardless of birthweight. 1, 2

Maternal HBsAg Status-Based Algorithm

Mother is HBsAg-Positive

For infants ≥2,000 grams:

• Birth (≤12 hours): First dose of hepatitis B vaccine + HBIG (0.5 mL) at separate sites 1
• 1-2 months: Second vaccine dose
• 6 months: Third vaccine dose (final dose must not be given before 24 weeks of age)

For infants <2,000 grams:

• Birth (≤12 hours): First dose of hepatitis B vaccine + HBIG (0.5 mL) at separate sites 1
• 1 month: Second vaccine dose (note the earlier timing compared to larger infants)
• 2-3 months: Third vaccine dose
• 6 months: Fourth vaccine dose (these smaller infants require 4 total doses; final dose must not be given before 24 weeks of age) 1

Critical timing note: HBIG efficacy decreases markedly if delayed beyond 48 hours 2. The FDA label explicitly states HBIG should be given "preferably within 12 hours of birth" and that "efficacy decreases markedly if treatment is delayed beyond 48 hours." 2

Mother's HBsAg Status is Unknown

For infants ≥2,000 grams:

• Birth (≤12 hours): First dose of hepatitis B vaccine only (hold HBIG while awaiting maternal test results) 1
• Draw maternal blood immediately and test for HBsAg
• If mother tests HBsAg-positive: Give HBIG as soon as possible but no later than 7 days of age, then complete series as for HBsAg-positive mothers 1
• If mother tests HBsAg-negative: Complete series as for HBsAg-negative mothers

For infants <2,000 grams:

• Birth (≤12 hours): Give BOTH vaccine AND HBIG immediately if maternal status cannot be determined within 12 hours 1
• This birth dose does NOT count toward the vaccine series
• Give 3 additional vaccine doses (total of 4 doses) based on eventual maternal HBsAg result 1

Rationale for weight-based approach: Smaller infants have potentially decreased vaccine immunogenicity, necessitating both immediate passive and active immunization when maternal status is uncertain 1.

Mother is HBsAg-Negative

For infants ≥2,000 grams:

• Hospital discharge or 1 month: First vaccine dose
• 2 months: Second dose
• 6-18 months: Third dose (final dose must not be given before 24 weeks of age) 1

For infants <2,000 grams:

• Hospital discharge or 1 month: First vaccine dose
• 2 months: Second dose
• 4 months: Third dose
• 6 months: Fourth dose 1

Post-Vaccination Testing for High-Risk Infants

For infants born to HBsAg-positive mothers:

• Test at 9-12 months of age (not before 9 months to avoid detecting passive anti-HBs from HBIG) 1
• Test for both HBsAg and anti-HBs 1
• Do NOT test for anti-HBc (passively acquired maternal antibody can persist up to 24 months) 1

Interpretation and management:

• Anti-HBs ≥10 mIU/mL and HBsAg-negative: Protected, no further action 1
• Anti-HBs <10 mIU/mL and HBsAg-negative: Give one additional vaccine dose, retest in 1-2 months 1
  • If still <10 mIU/mL after single dose: Complete a second full 3-dose series, then retest 1-2 months after final dose 1
  • No benefit from more than two complete vaccine series 1
• HBsAg-positive: Infant has chronic HBV infection; refer for specialist follow-up 1

Critical Implementation Points

Administration technique:

• HBIG and vaccine must be given at separate anatomical sites (e.g., different limbs) 1, 2
• Both are given intramuscularly 2
• Use only single-antigen hepatitis B vaccine for birth dose (combination vaccines like Pediarix cannot be used before 6 weeks of age) 1

Common pitfall: The 2018 ACIP guidelines emphasize that even with maternal antiviral therapy during pregnancy, newborns still require full immunoprophylaxis (vaccine + HBIG) within 12 hours 3. Two cases of vertical transmission occurred in 2019 despite timely immunoprophylaxis when maternal viral loads were detected too late for antiviral prophylaxis 4, underscoring that immunoprophylaxis remains the cornerstone of prevention.

Breastfeeding: Infants who receive immunoprophylaxis at birth may breastfeed immediately 1, 3.

Facility transfers: When infants are transferred between facilities, explicit communication about immunoprophylaxis status is mandatory to prevent missed or duplicate doses 1.